Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00189592 · ClinicalTrials.gov registry record · Phase 4
Plantar Fasciosis Treatment Using Coblation
A Phase 4 study, sponsored by ArthroCare Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00189592 is a Phase 4 study that has completed, run by ArthroCare Corporation. The registered enrollment target is 45 participants.
The verdict
NCT00189592, a Phase 4 study, has completed, sponsored by ArthroCare Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of Coblation-based fasciotomy for relieving pain associated with recurring plantar fasciosis and, secondarily, to determine whether there may be additional potential benefits stemming from its use.
Interventions
- DEVICE ArthroCare TOPAZ™ MicroDebrider™ using Coblation
- PROCEDURE Surgical Fasciotomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00189592
The ClinicalTrials.gov registry entry for NCT00189592 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ArthroCare Corporation, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ArthroCare TOPAZ™ MicroDebrider™ using Coblation is the first listed.
NCT00189592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00189592 about?
NCT00189592 is a clinical study titled "Plantar Fasciosis Treatment Using Coblation". The purpose of this study is to evaluate the effectiveness of Coblation-based fasciotomy for relieving pain associated with recurring plantar fasciosis and, secondarily, to determine whether there may be additional potential benefits stemming from its use.
What is the current status of trial NCT00189592?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2005-08. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00189592?
The interventions under investigation include: ArthroCare TOPAZ™ MicroDebrider™ using Coblation (DEVICE), Surgical Fasciotomy (PROCEDURE).
Who is sponsoring clinical trial NCT00189592?
This trial is sponsored by ArthroCare Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.